Clinical Trial Update: GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing indobufen vs aspirin for patients on dual antiplatelet therapy in coronary artery disease and gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Gastroesophageal Reflux Disease

Drugs mentioned

• Aspirin (Aspirin)
• Indobufen (indobufen)

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Coronary Artery Disease, Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN